(secondQuint)A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013).

 This study is planned to be conducted in two parts.

 Part 1 of the study will include participants with moderate hepatic insufficiency and healthy participants.

 If Part 2 is conducted, Part 2 of the study will include participants with mild hepatic insufficiency.

.

 A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)@highlight

This study will investigate the pharmacokinetics of a single oral dose of vibegron (MK-4618) administered to participants with moderate hepatic insufficiency and healthy participants matched for age, gender, and body mass index (BMI).

 Participants may be enrolled with mild hepatic insufficiency.

